Zantac (Brand)

gastro health
Ranitidine 150mg
(Brand) GSK
60Tablets51 €Buy Now
Ranitidine 300mg
(Brand) GSK
60Tablets68 €Buy Now

Zantac (Generic)

Ranitidine 150mg (Generic)100Tablets43 €Buy Now
Ranitidine 300mg (Generic)100Tablets47 €Buy Now

Lanzor (Brand)

Lanzoprazol 15mg (Brand)
Aventis
30Caps74 €Buy Now
Lanzoprazol 30mg (Brand)
Aventis
30Caps95 €Buy Now

Lanzor (Generic)

Lanzoprazol 15mg (Generic)40Tablets70 €Buy Now
Lanzoprazol 30mg (Generic)40Tablets78 €Buy Now

Losec (Brand)

Omeprazole 20mg
(Brand) Astra
28CapsAnti-Acid86 €Buy Now

Losec (Generic)

Omeprazole 20mg (Generic)50CapsAnti-Acid65 €Buy Now
Omeprazole 40mg (Generic)50CapsAnti-Acid78 €Buy Now

Ranitidine, sold under the trade name Zantac among others, is a medication which decreases stomach acid production.[2] It is commonly used in treatment of peptic ulcer disease, gastroesophageal reflux disease, and Zollinger–Ellison syndrome.[2] There is also tentative evidence of benefit for hives.[4] It can be taken by mouth, by injection into a muscle, or into a vein.[2]

Common side effects include headaches and pain or burning if given by injection.[2] Serious side effects may include liver problems, a slow heart rate, pneumonia, and the potential of masking stomach cancer.[2] It is also linked to an increased risk of Clostridium difficilecolitis.[5] It is generally safe in pregnancy.[2] Ranitidine is an H2 histamine receptor antagonist that works by blocking histamine and thus decreasing the amount of acid released by cells of the stomach.[2]

Ranitidine was discovered in 1976, and came into commercial use in 1981.[6] It is on the World Health Organization’s List of Essential Medicines, the safest and most effective medicines needed in a health system.[7] It is available as a generic medication.[2] The 2015 wholesale price in the developing world was about US$0.01–0.05 per pill.[8] In the United States it is about $0.05 per dose.[2] In 2016, it was the 50th most prescribed medication in the United States with more than 15 million prescriptions.[9] In September 2019, the toxin N-nitrosodimethylamine was discovered to occur in ranitidine from a number of manufacturers, resulting in distribution stops and recalls